# BioPacific Investors

> BioPacific Investors is a VC fund backing Biotechnology, Medical Device and Medical. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 2
- Last investment: Feb 2021
- Lead investor: 0%
- Last updated: Aug 2026

BioPacific Investors is a VC fund focused on Biotechnology and Medical Device. BioPacific Investors leverages cross-pacific business opportunities by investing in early-stage life science and healthcare companies.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Medical Device | 2 | 100% |
| Medical | 1 | 50% |
| Health Care | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Convertible Note | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Synova Life Sciences | Synova Life Sciences device that gets stem cells from fat. It's 30 times faster than the current gold standard and typically yields 1.5 to 2.5 times more cells. Processing takes less than 3 minutes and uses no enzymes or other chemical additives. | $1.9M | Seed | Feb 01, 2021 |  |
| NovaScan | NovaScan provides diagnostic products that apply bioelectrical impedance to assess tissue characteristics relevant to cancer detection. Its MarginScan device performs ex vivo and in vivo margin evaluation by generating immediate electrical measurements during clinical procedures. The nsCanary tool examines biopsy cores directly after sampling toindicate whether malignant tissue is present. NovaScan also uses machine-learning models to interpret impedance signatures and distinguish cancerous from non-cancerous tissue. These products are designed to support clinical decision-making through rapid, instrument-based analysis. | $3M | Convertible Note | Jan 22, 2021 |  |

2 of 2 investments shown.

## Co-investors
- [Asymmetry Ventures](https://shizune.co/investors/profile/asymmetry-ventures) — VC Fund, 1 deal together
- [Canaan Partners](https://shizune.co/investors/profile/canaan-partners) — VC Fund, 1 deal together
- [Green Park & Golf Ventures](https://shizune.co/investors/profile/green-park-golf-ventures) — VC Fund, 1 deal together
- [Hanmi Healthcare](https://shizune.co/investors/profile/hanmi-healthcare-bb61) — VC Fund, 1 deal together
- [Harvard Business School Angels Chicago](https://shizune.co/investors/profile/harvard-business-school-angels-chicago) — VC Fund, 1 deal together
- [Stateline Angels](https://shizune.co/investors/profile/stateline-angels) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does BioPacific Investors invest in?

BioPacific Investors invests primarily in Biotechnology, Medical Device and Medical startups, most often at Seed and Convertible Note stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did BioPacific Investors last invest?

The most recent investment recorded for BioPacific Investors closed in Feb 2021. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co